Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients
- PMID: 25690848
- DOI: 10.1007/s15010-015-0743-4
Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients
Abstract
Introduction: Solid organ transplant recipients are especially susceptible to healthcare-associated infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp-HAIs). The aim of the study was to evaluate risk factors and outcome of these infections in kidney transplant recipients.
Methods: This was a retrospective cohort of kidney transplant (KTx) recipients between January 2009 and December 2013. Cases were defined as patients who developed KPC-Kp-HAI, confirmed by PCR for bla( KPC) gene after KTx during the study period. We analysed variables related to recipient; induction immunosuppressant therapy; delayed graft function; use of invasive devices; SOFA score on the first day of infection; type of therapy; time from positive culture to appropriate antimicrobial therapy; bacteraemia; and concomitant infection. Outcome measures were the occurrence of KPC-Kp-HAI and 30-day mortality after KPC-Kp-HAI.
Results: A total of 1,101 were submitted to KTx in the period, 21 patients were classified as infected with KPC-Kp. Another ten patients had KPC-Kp-HAI in the period and were transplanted before 2009. Of those 31 patients, 48.4 % showed evidence of prior colonization and 38.7 % had bacteraemia. The most common site of infection was the surgical wound. Risk factors for KPC-Kp-HAI were multi-organ transplantation and the use of a ureteral stent. Eight of the infected patients experienced recurrence of the infection. The 30-day mortality rate was 41.9 %. Survival was significantly lower among the patients with KPC-Kp-HAI (72 vs. 89.1 %; P = 0.002). The only risk factor independently associated with 30-day mortality was an elevated SOFA score on the first day of infection.
Conclusions: In KTx recipients, the occurrence of KPC-Kp-HAI was related to invasive devices and type of transplant; these infections had a high rate of recurrence and reduced survival after KTx.
Similar articles
-
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.Scand J Infect Dis. 2014 Sep;46(9):642-8. doi: 10.3109/00365548.2014.923106. Epub 2014 Jul 14. Scand J Infect Dis. 2014. PMID: 25017796
-
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):277-86. doi: 10.1007/s10096-014-2233-5. Epub 2014 Aug 30. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25169967
-
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.Clin Microbiol Infect. 2016 May;22(5):444-50. doi: 10.1016/j.cmi.2016.01.016. Epub 2016 Feb 3. Clin Microbiol Infect. 2016. PMID: 26850826
-
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.Future Microbiol. 2015;10(2):283-94. doi: 10.2217/fmb.14.121. Future Microbiol. 2015. PMID: 25689539 Review.
-
Epidemiology and outcome of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review.J Chemother. 2019 Nov-Dec;31(7-8):359-366. doi: 10.1080/1120009X.2019.1685794. Epub 2019 Nov 8. J Chemother. 2019. PMID: 31701842 Review.
Cited by
-
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.Eur J Clin Microbiol Infect Dis. 2023 May;42(5):529-541. doi: 10.1007/s10096-023-04578-w. Epub 2023 Mar 1. Eur J Clin Microbiol Infect Dis. 2023. PMID: 36856898 Free PMC article.
-
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series.Infection. 2017 Apr;45(2):209-213. doi: 10.1007/s15010-016-0968-x. Epub 2017 Feb 9. Infection. 2017. PMID: 28185222
-
Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection.Chin Med J (Engl). 2018 Jan 5;131(1):56-62. doi: 10.4103/0366-6999.221267. Chin Med J (Engl). 2018. PMID: 29271381 Free PMC article.
-
Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.Ther Adv Infect Dis. 2017 Nov;4(6):171-191. doi: 10.1177/2049936117733394. Epub 2017 Oct 17. Ther Adv Infect Dis. 2017. PMID: 29662673 Free PMC article. Review.
-
Evaluation of the Therapeutic Outcomes of Antibiotic Regimen Against Carbapenemase-Producing Klebsiella pneumoniae: A Systematic Review and Meta-Analysis.Front Pharmacol. 2021 Nov 4;12:597907. doi: 10.3389/fphar.2021.597907. eCollection 2021. Front Pharmacol. 2021. PMID: 34803661 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical